Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Status Check: Point-of-Care Testing in Hospitals

This article was originally published in Start Up

Executive Summary

The in vitro diagnostics industry has looked for years to point-of-care testing in hospitals as a growth segment. The premise is sound--easy-to-use tests performed near the patient will yield faster results that enable physicians to make better on-the-spot treatment decisions. In reality, hospital demand is increasing, but not as fast as expected. A recent survey of one-third of US hospitals with 150 beds or more, by Enterprise Analysis Corp. seeks to understand POCT usage and demand trends.

You may also be interested in...



Hospitals' Hang-Ups With Point-Of-Care Testing

The hospital market for point-of-care testing represents a conundrum for manufacturers. Demand for it is growing--but, with the exception of glucose monitoring, not as fast as proponents had expected. A recent survey of a third of US hospitals with 150 or more beds seeks to gather information about hospital point-of-care testing utilization and preferences.

Hospitals' Hang-Ups With Point-Of-Care Testing

The hospital market for point-of-care testing represents a conundrum for manufacturers. Demand for it is growing--but, with the exception of glucose monitoring, not as fast as proponents had expected. A recent survey of a third of US hospitals with 150 or more beds seeks to gather information about hospital point-of-care testing utilization and preferences.

Robust Times for Diagnostic Companies

The diagnostic industry's buoyant health was evident at this year's American Association for Clinical Chemistry meeting in Los Angeles. Floor space was sold out and attendance hit a record. In contrast to a malaise in the industry through much of the 1990s, diagnostics now have reimbursement, demographic, and labor shortage trends in their favor. At $24.9 billion in revenues, experts say the industry is poised to deliver another year of double-digit growth, following an 11% gain in 2003.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel